RM

Rajeev Mandal

Active Director Designated Partner DIN 09103238
DIN 09103238 First appointment Mar 2021 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajeev Mandal

Data last updated:

Rajeev Mandal is a Designated Partner at Syno Merck Pharmaceuticals Llp (since 2021). The company operates in Business Services.

DIN 09103238
Primary Designation Designated Partner
Industry Business Services
First Appointment 12 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Mar 20212021Active

Board colleagues of Rajeev Mandal

NameDINCompanyDesignation
Piyush Raj09103237Syno Merck Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Syno Merck Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Rajeev Mandal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Mandal

Rajeev Mandal currently holds 1 directorship: Syno Merck Pharmaceuticals Llp (Designated Partner, since 12 Mar 2021).

Rajeev Mandal was first appointed on 12 Mar 2021 as Designated Partner at Syno Merck Pharmaceuticals Llp.

The current boards of Rajeev Mandal's companies include Piyush Raj (Syno Merck Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available